Dear nmusers members:
ICON will be hosting a booth at the ASCPT 2015 meeting in New Orleans. Meet us
at booth #111 to discuss your Early Phase drug development requirements,
population PK/PD analysis and NONMEM/PDx-Pop. ICON delivers expertise in the
design, study conduct and interpretation of
MERCK SERONO IS THE BIOPHARMACEUTICAL DIVISION OF MERCK
At Merck Serono, we discover, develop, manufacture and market innovative small
molecules and biopharmaceuticals in our focus therapeutic areas:
* Oncology
* Neurodegenerative diseases
* Fertility
*
